product portfolio
What we do
APIs and Intermediates:
We are a specialized pharma company focusing on niche therapeutic areas of CNS, ARVs and controlled substances. Our specialization in unique CNS segments like ADHD, Anti-psychotics, Anti-vertigo, Anti-inflammatory, Pain management, Alzheimer disease and others gives ZCL the leverage to outclass the competition. We are moving up the value chain adding capacity for more APIs.

CMO:
With the best in class manufacturing facilities with accreditation and state-of-the-art research platform besides brilliant minds in our R&D we have embarked on establishing contract manufacturing organization. We have many on-going contract manufacturing projects that involve complex chemistry and technological excellence.

Active Pharma Ingredients (APIs)
Product Status Pharmacoepeia CAS No. Therapeutic Use Enquiry
Alprazolam Tech pack USP/EP 28981-97-7 Anxiolytic Enquire Now
Aripiprazole USDMF⁺, CEP USP/EP 129722-12-9 Anti-depressant/Anti-psychotic Enquire Now
Atomoxetine HCl CEP, USDMF, TDMF, IDL* USP/EP 82248-59-7 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Betahistine Dihydrochloride CEP, TDMF USP/BP/EP/IP 5579-84-0 Vertigo Enquire Now
Betahistine Mesylate Tech pack EP/JP/IP 54856-23-4 Vertigo Enquire Now
Clozapine USDMF⁺, CEP* USP/EP/IP 5786-21-0 Anti-psychotic Enquire Now
Dexmethylphenidate HCl Tech pack Inhouse 19262-68-1 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Eslicarbazepine Acetate USDMF*, EDMF* In-house/IP 236395-14-5 Anti-epileptic Enquire Now
Felbinac EDMF, JDMF* BP/EP/JP 5728-52-9 Anti-inflammatory Enquire Now
Fluvoxamine Maleate CEP, USDMF⁺, TDMF USP/BP/EP/IP 61718-82-9 Anti-depressant Enquire Now
Levomepromazine Maleate CEP* EP/JP 7104-38-3 Anti-psychotic Enquire Now
Loxoprofen sodium Tech pack JP 80382-23-6 Anti-inflammatory, Analgesic Enquire Now
Lurasidone HCl USDMF⁺ In-house 367514-88-3 Anti-psychotic Enquire Now
Memantine HCl USDMF, AUSDMF USP 41100-52-1 Alzheimer Disease Enquire Now
Methylphenidate HCl CEP USP/EP 298-59-9 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Mirabegron Tech pack In-house 223673-61-8 Treatment of overactive bladder Enquire Now
Modafinil Tech pack USP/EP 68693-11-8 CNS Stimulant Enquire Now
Olanzapine Tech pack USP 132539-06-1 Anti-psychotic Enquire Now
Phenylephrine hydrochloride Tech pack EP/IP 61-76-7 Decongestant Enquire Now
Pirfenidone USDMF* & CEP EP/IP 53179-13-8 Anti-Inflammatory / Anti-Rheumatic Enquire Now
Pregabalin Tech pack In-house 148553-50-8 Epilepsy, Neuropathic pain and generalized anxiety disorder Enquire Now
Quetiapine Fumarate USDMF⁺, AUSDMF & CEP USP/EP 111974-72-2 Anti-psychotic Enquire Now
Rivaroxaban USDMF In-house 366789-02-8 Anti-coagulant Enquire Now
Trifluoperazine HCl Tech pack USP/BP/EP/IP 440-17-5 Anti-psychotic Enquire Now
Zaltoprofen KDMF JP 74711-43-6 Anti-inflammatory Enquire Now
Zonisamide USDMF USP 68291-97-4 Anti-convulsant Enquire Now
 
Product Pipeline
Apixaban Under development In-house 503612-47-3 Anticoagulant Enquire Now
Dapagliflozin propanediol monohydrate Under development In-house 960404-48-2 Anti-diabetic Enquire Now
Darunavir ethanolate Under development In-house 635728-49-3 Treatment of AIDS and HIV infections Enquire Now
Empagliflozin Under development In-house 864070-44-0 Anti-diabetic Enquire Now
Ticagrelor Under development In-house 274693-27-5 Platelet aggrega Enquire Now
 
Product under evaluation
Betrixaban Under evaluation In-house 330942-05-7 Anticoagulant Enquire Now
Brivaracetam Under evaluation In-house 357336-20-0 Anti-Epileptics;Analgesics Enquire Now
Dabigatran Etexilate Mesylate Under evaluation In-house 872728-81-9 Anticoagulant Enquire Now
Ertugliflozin Under evaluation In-house 1210344-57-2 Anti-diabetic Enquire Now
Pimavanserin Under evaluation In-house 706779-91-1 Antipsychotic Enquire Now
Safinamide Mesylate Under evaluation In-house 133865-89-1 Anti-Epileptics;Anti-Parkinson Drugs Enquire Now
Trimebutine Maleate Under evaluation In-house 34140-59-5 Antimuscarinic Enquire Now
* Under filing, + DMF Info Available for Reference
Disclaimer:
Users are responsible for all patent related issue for our offered products.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC 271 (e) (1)

Advanced Intermediates
Product CAS No. End Use Structure Enquiry
(1H)-7-(4’-bromobutoxy)-3,4-dihydro-2-quinolinone 1297225-34-5 Aripiprazole Enquire Now
1-(2,3-Dichlorophenyl) Piperazine HCl 119532-26-2 Aripiprazole Enquire Now
3-(methylamino)-1-phenylpropan-1-ol 42142-52-9 Atomoxetine Fluoxetine Nisoxetine Enquire Now
N-Benzhydrylpiperazine 841-77-0 Cinnarizine Enquire Now
Benzenesulfonamide, 4-amino-N-[(2R,3S)-3-amino-2- hydroxy-4-phenylbutyl]-N-(2-methylpropyl) 169280-56-2 Darunavir Enquire Now
Carbamic acid, N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1- (phenylmethyl)propyl]-,1,1-dimethylethylester 191226-98-9 Darunavir, Fosamprenavir Enquire Now
N-(1,4-Benzodioxan-2-carbonyl)-piperazine 70918-00-2 Doxazosin Enquire Now
(10S)-10,11-Dihydro-10-hydroxy-5Hdibenz[b,f]azepine-5-carboxamide 104746-04-5 Eslicarbazepine acetate Enquire Now
10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide 29331-92-8 Eslicarbazepine acetate Enquire Now
4-Hydroxy-3, 5-dimethyl benzonitrile 4198-90-7 Etravirine Enquire Now
4,4'-Difluorobenzhydrylpiperazine 27469-60-9 Flunarizine Enquire Now
(1E)-N-Hydroxy-5-Methoxy-1-(4-Trifluoromethylphenyl)Pentan-1-Imine 61747-22-6 Fluvoxamine Enquire Now
2-Bromo-4'-benzyloxy-3'-nitroacetophenone 43229-01-2 Formoterol Enquire Now
2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1- piperazinyl]phenyl]-2-(1-methyl propyl)-3H-1,2,4-triazol-3-one 252964-68-4 Itraconazole Enquire Now
1-Acetyl-4-(4-hydroxyphenyl) piperazine 67914-60-7 Ketoconazole Enquire Now
2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid 68767-14-6 Loxoprofen Sodium Enquire Now
1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol hydrochloride 521284-22-0 Mirabegron Enquire Now
(1R)-2-{[2-(4-nitrophenyl)ethyl]amino}-1-phenylethanol 223673-34-5 Mirabegron Enquire Now
2-Methyl-10H-thieno[2,3-b][1,5] benzo diazepine-4-amine HCl 138564-60-0 Olanzapine Enquire Now
5-methyl-2-(2-nitrophenylamino) thiophene-3-carbonitrile 138564-59-7 Olanzapine Enquire Now
(R)-(-)-3-Carbamoylmethyl-5-methylhexanoic acid 181289-33-8 Pregabalin Enquire Now
5-methylpyridin-2(1H)-one (synonym : 2-Hydroxy-5-methylpyridine) 1003- 68-5 Pirfenidone Enquire Now
1-Aminoindan 34698-41-4 Rasagiline Enquire Now
4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride 898543-06-1 Rivaroxaban Enquire Now
2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 446292-08-6 Rivaroxaban Enquire Now
N-Isopropyl-4-(4-hydroxyphenyl)-piperazine 67914-97-0 Terconazole Enquire Now
2-(Trifluoromethyl)-phenothiazine 92-30-8 Trifluoperazine Enquire Now
Disclaimer:
Users are responsible for all patent related issue for our offered products.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC 271 (e) (1)
Intermediate for controlled substances
Product CAS No. End Use Structure Enquiry
N-[1-(benzyl)-4-(methoxymethyl)-4-piperidinyl]-N-phenyl Propanamide oxalate 61086-13-3 Alfentanil & Sufentanil Enquire Now
N-[4-(methoxymethyl)-piperidine-4-yl]-N-phenylpropanamide monohydrochloride 84196-16-7 Alfentanil & Sufentanil Enquire Now
N-(1-Benzylpiperidin-4-yl)-N-phenylpropanamide Hydrochloride 5156-58-1 Fentanil Enquire Now
Methyl 4-(phenyl-propionyl-amino)-piperidine-4-carboxylate HCl 61085-87-8 Remifentanil Enquire Now
N-[(4-Methoxymethyl)-4-piperidinyl]-N-phenylpropanamide 61086-18-8 Sufentanil Enquire Now
*USDMF available
Disclaimer:
Users are responsible for all patent related issue for our offered products.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 335 USC 271 (e) (1)
Methyl Phenidate Series
Product CAS No. Structure Enquiry
Phenyl-(2-pyridyl acetamide) 7251-52-7 Enquire Now
Phenyl-2-(2'-piperidyl)acetamide 19395-39-2 Enquire Now
Threo phenyl-2-piperidyl acetamide* 50288-62-5 Enquire Now
dl-threo ritalinic acid* 54631-24-2 Enquire Now
dl-Threo-Ritalinic acid HCl 1382859-13-3 Enquire Now
d-threo ritalinic acid hydrohloride* 741705-70-4 Enquire Now
Under Scale-up / New Development
Product CAS No. End Use Status Structure Enquiry
1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,2,3,4,6-tetraacetate, (1S)- D-Glucitol 461432-25-7 Dapagliflozin propanediol Under development Enquire Now
(2S,3R,4S,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol 714269-57-5 Dapagliflozinpropanediol Under development Enquire Now
1-Choro-4-(B-D-glucopyranos-1yl)-2-(4-hydroxy-benzyl)-benzene 864070-37-1 Empagliflozin Under development Enquire Now
4-(5-bromo-2-chlorobenzyl) phenol(synonym : [(5-bromo-2-chlorobenzyl)-methyl] phenol 864070-18-8 Empagliflozin Under development Enquire Now
(4-(5-bromo-2-chlorobenzyl)phenoxy)(tertbutyl)dimethylsilane 864070-19-9 Empagliflozin Under development Enquire Now
(2S,3S,4R,5R,6R)-2-(3-(4-acetoxybenzyl)-4-chlorophenyl)-6-(acetoxymethyl)tetrahydro-2Hpyran-3,4,5-triyltriacetate 912917-85-2 Empagliflozin Under development Enquire Now
(R)-tetrahydrofuran-3-yl 4-methylbenzene sulfonate 219823-47-9 Empagliflozin Under development Enquire Now
4-Amino-2-fluoro-N-methylbenzamide 915087-25-1 Enzalutamide Underscale-up Enquire Now
N-Methyl-2-fluoro-4-(1,1-dimethyl cyanomethyl) aminobenzamide 915087-32-0 Enzalutamide Under scaleup Enquire Now
Disclaimer:
Users are responsible for all patent related issue for our offered products.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC 271 (e) (1)

Disclaimer
Information given herein is offered in good faith as accurate, but without guarantee. Conditions of use and suitability of the product for particular uses are beyond our control. All risks of use of the product are therefore assumed by the user. ZCL Chemicals Limited EXPRESSLY DISCLAIMS ALL WARRANTIES OF EVERY KIND AND NATURE, INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE IN RESPECT TO THE USE OR SUITABILITY OF THE PRODUCT. Appropriate warnings and safe handling procedures should be provided to handlers and users.

Alteration of this document is strictly prohibited.

No statement contained herein concerning a possible or suggested use of any material, product or design is intended, or should be construed, to grant any license under any patent or other intellectual property right of ZCL Chemicals Limited or any of its associates or its affiliates covering such use or design, or as a recommendation for the use of such material, product or design in the infringement of any patent or other intellectual property right. The products are sold subject to ZCL Chemicals Limited Standard Conditions of Sale, which are available upon request.
Socialize with us